US Patent Issued to BioLegend on July 14 for "Anti-TLR7 agents and compositions and methods for making and using the same" (California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,901, issued on July 14, was assigned to BioLegend Inc. (San Diego).

"Anti-TLR7 agents and compositions and methods for making and using the same" was invented by Takatoku Oida (San Diego), Anagha Ashok Divekar (San Diego), Shawna Ann Shirley (San Diego) and Nicole Vivienne Acuff (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods for making and using anti-TLR7 agents, for example, monoclonal antibodies, TLR7-binding antibody fragments, and derivatives are described, as are kits, nucleic acids encoding such molecules, diagnostic reagents and kits that include anti-TLR7 agents, and methods of making and using the same."...